echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > Int J Hematol: Romibutine can effectively treat Eltrombopag refractory aplastic anemia

    Int J Hematol: Romibutine can effectively treat Eltrombopag refractory aplastic anemia

    • Last Update: 2021-08-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Eltrombopag (EPAG) and romiplostim (ROM) are thrombopoietin receptor antagonists.
    Prospective controlled studies have confirmed that they are effective against aplastic anemia (AA).
    They were authorized to treat adults in Japan in 2017 and 2019, respectively Patients with aplastic anemia
    .


    However, to date, there is no data on the potential contribution of switching from ROM to EPAG or vice versa in terms of efficacy or tolerability


    These 10 patients did not respond to the maximum dose of EPAG and then switched to ROM
    .


    All 10 patients received the maximum dose of ROM (20μg/kg/week)


    immunity

    In summary, although more patients and a longer follow-up period are needed to confirm the results of the study, the results of the study show the efficacy of ROM in patients with EPAG refractory AA


     

    Original source:

     

    Masataka Ise, et al.


    Romiplostim is effective for eltrombopag-refractory aplastic anemia: results of a retrospective study in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.